# Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/q4b-evaluation-and-recommendation-of-pharmacopoeial-texts-for-use-in-the-international-conference-on-harmonisation-regions/ed4cda87-18d7-4f82-acd8-1d3fee51bdc8

> FDA guidance document: Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions. Issue date: February 20, 2008. Get complete insights and analysis.

---

## Details

- Title: Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2008-02-20
- Last Changed: 2020-04-13
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2008-D-0081">FDA-2008-D-0081</a>

## Related Documents

- [E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/e14-clinical-evaluation-of-qtqtc-interval-prolongation-and-proarrhythmic-potential-for-non-antiarrhythmic-drugs/c83f1589-7be1-4064-93e8-eedcbfd73f95)
- [S8 Immunotoxicity Studies for Human Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/s8-immunotoxicity-studies-for-human-pharmaceuticals/216b9605-e0e0-4dd4-a10b-a51326a268f5)
- [M4: The CTD -- Safety Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/m4-the-ctd-safety-questions-and-answers/3d7d73b1-cced-46a8-bc54-4914a6e06b8f)